The table below shows Tyra Biosciences, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$95.14M
-$69.77M
-$50.14M
-$50.28M
-$23.75M
-$7.76M
Capital expenditure
$141.00K
$664.00K
$770.00K
$559.00K
$661.00K
$312.00K
Investing cash flow
$72.46M
-$98.40M
-$144.60M
-$559.00K
-$645.00K
-$312.00K
Dividends paid
-
-
-
-
TYRA operating cash flow (10-K history)
Tyra Biosciences, Inc. reported operating cash flow of -$95.14M for fiscal year 2025. That is down 36.4% from -$69.77M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$7.76M (FY 2020) to -$95.14M. Figures come from the company's audited annual reports as filed with the SEC.